Tourbillon Capital Partners, L.P. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 17 filers reported holding KRYSTAL BIOTECH INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tourbillon Capital Partners, L.P. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2018$2,482,000
-18.7%
141,198
-31.2%
0.27%
+126.3%
Q2 2018$3,052,000
+19.9%
205,236
-18.7%
0.12%
+16.8%
Q1 2018$2,546,000
-4.1%
252,3480.0%0.10%
+3.1%
Q4 2017$2,655,000
+6.5%
252,348
+0.9%
0.10%
+63.3%
Q3 2017$2,493,000250,0000.06%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 1,913,280$153,177,1976.65%
Frazier Life Sciences Management, L.P. 945,407$75,689,2845.48%
S Squared Technology, LLC 108,215$8,663,6935.14%
Nicholas Investment Partners, LP 374,718$29,999,9232.28%
Avoro Capital Advisors LLC 1,750,000$140,105,0002.08%
Artal Group S.A. 412,082$32,9911.96%
First Light Asset Management, LLC 195,980$15,690,1591.41%
Integral Health Asset Management, LLC 85,000$6,805,1001.37%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$4,883,6601.36%
Hood River Capital Management LLC 447,393$35,818,0001.16%
View complete list of KRYSTAL BIOTECH INC shareholders